Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 2

Status Completed

Clinical Trial Summary

The purpose of this study is to adapt and test the effects of a 4-week behavioral treatment that targets chronic insomnia (lasting >1 month) in service members returning from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF), finalizing a treatment manual.

Clinical Trial Description

Insomnia is one of the most common reasons for referral to mental health services in active duty personnel. Chronic insomnia often persists post-deployment, contributes to poor mental and physical health outcomes, and requires targeted interventions. Effective behavioral treatments of insomnia have not been adapted and tested for the treatment of chronic insomnia comorbid to combat-related mental disorders and stress reactions. In addition, effective behavioral insomnia treatments are typically delivered over an 8-week period. This format may not be easily exportable to primary and community care settings where military returnees and veterans seek help. The goal is to adapt and test the effects of a 4-week behavioral treatment that targets chronic insomnia (lasting >1 month) in service members returning from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF), and who present with the typical psychiatric comorbidities associated of combat-related anxiety and mood disorders and stress reactions. We call this intervention the Brief Behavioral Treatment of Insomnia for Military Veterans (BBTI-MV). The proposed study includes two phases. The specific aims of Phase II are: (1) To explore the effects of BBTI-MV on sleep and daytime symptoms of psychiatric distress. We anticipate that participants randomized to BBTI-MV will show a higher categorical response rate and remission for sleep symptoms than subjects randomized to IC. (2) To evaluate in a preliminary manner the durability of therapeutic gains and by conducting a naturalistic follow-up assessment six months post-treatment in responders. (3) To explore whether the nature of combat-related experiences, time since deployment and since, return to the US, deployment theater, medication use and change in dosage, mood and anxiety or disorders affect sleep treatment adherence and outcomes. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Chronic Insomnia

Clinical Trial Details

NCT number	NCT00840255
Study type	Interventional
Source	University of Pittsburgh
Contact
Status	Completed
Phase	N/A
Start date	April 2009
Completion date	April 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03171519` - Effects of Exercise and Acupuncture on Chronic Insomnia	N/A
Completed	`NCT02515006` - Impact of Homeopathy for Persistent Insomnia in Patients With Cancer	N/A
Recruiting	`NCT05247697` - Mirtazapine for Chronic Insomnia in Older Adults	Phase 1
Active, not recruiting	`NCT04350866` - Enhancing Access to Insomnia Care in VA PCMHI Clinics
Active, not recruiting	`NCT04366284` - Optimizing the Scalability of Evidence-Based Behavioral Sleep Medicine Practices With a Digital Health Platform	N/A
Recruiting	`NCT04761796` - Sleep Time and Insomnia Factors Among Professional Flight Members
Completed	`NCT02688569` - Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study	N/A
Completed	`NCT02236845` - Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients	N/A
Completed	`NCT01949389` - Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders	N/A
Completed	`NCT00414102` - Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.	Phase 4
Completed	`NCT00671294` - Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.	Phase 3
Completed	`NCT02392000` - Mobile Sleep Intervention for OEF, OIF and OND Veterans	N/A
Recruiting	`NCT04471168` - Interest of Auriculotherapy in the Management of Chronic Insomnia	N/A
Completed	`NCT02774642` - Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)	N/A
Completed	`NCT02290405` - Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
Completed	`NCT05618002` - Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients
Completed	`NCT01995838` - A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia	Phase 2
Recruiting	`NCT05457790` - Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)	N/A
Completed	`NCT02272712` - The Effectiveness of Online Treatment for Insomnia in Cancer Survivors	N/A
Completed	`NCT00915135` - Efficacy and Safety of Ramelteon on Chronic Insomnia	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 2 (BBTIMVII) — BBTIMVII

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms